Axogen (AXGN) Shares Outstanding (Weighted Average) (2010 - 2026)

Axogen (AXGN) recorded quarterly Shares Outstanding (Weighted Average) of $51.6 million in Q1 2026, up 12.03% quarter-over-quarter from $46.1 million in Q4 2025, and up 14.13% on a YoY basis from $45.2 million in Q1 2025.

Axogen (AXGN) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Axogen's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $51.6 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 14.13% year-over-year to $51.6 million; the TTM figure through Mar 2026 stood at $51.6 million (up 14.13% YoY), while the FY2025 annual figure was $46.1 million, up 4.05% from the prior year.
  • Shares Outstanding (Weighted Average) was $51.6 million for Q1 2026 at Axogen, up from $46.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $51.6 million in Q1 2026 to a low of $41.8 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $44.0 million across 5 years, with a median of $43.2 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Weighted Average) advanced 1.43% in 2024, then rose 14.13% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $42.1 million in 2022, then advanced by 1.89% to $42.9 million in 2023, then advanced by 3.22% to $44.3 million in 2024, then climbed by 4.05% to $46.1 million in 2025, then gained by 12.03% to $51.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $51.6 million (Q1 2026), $46.1 million (Q4 2025), and $45.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 382.90 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 456.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 98.20 Mn
10 Axogen 2.32 Bn 2.22 Bn 46.19 Mn 51.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.59 Mn
Dec 31, 2025 46.05 Mn
Sep 30, 2025 45.91 Mn
Jun 30, 2025 45.61 Mn
Mar 31, 2025 45.20 Mn
Dec 31, 2024 44.26 Mn
Sep 30, 2024 43.61 Mn
Jun 30, 2024 43.47 Mn
Mar 31, 2024 43.23 Mn
Dec 31, 2023 42.88 Mn
Sep 30, 2023 42.82 Mn
Jun 30, 2023 42.86 Mn
Mar 31, 2023 42.57 Mn
Dec 31, 2022 42.08 Mn
Sep 30, 2022 42.01 Mn
Jun 30, 2022 41.90 Mn
Mar 31, 2022 41.80 Mn
Dec 31, 2021 41.21 Mn
Sep 30, 2021 41.09 Mn
Jun 30, 2021 40.89 Mn